FDA Approves ZTALMY for CDKL5 Deficiency Disorder
source: pixabay.com

FDA Approves ZTALMY for CDKL5 Deficiency Disorder

Until recently, patients with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) did not have an FDA-approved treatment option. This all changed when the regulatory agency granted approval to ZTALMY, also…

Continue Reading FDA Approves ZTALMY for CDKL5 Deficiency Disorder